Answer
Oct 01, 2025 - 04:54 AM
Tetrabenazine is classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor. It is primarily used to treat movement disorders such as chorea associated with Huntington’s disease. By inhibiting VMAT2, it reduces the amount of certain neurotransmitters like dopamine in the brain.
